LungLife AI

LungLife AI is transforming cancer diagnosis and management through AI-enabled molecular analysis of cancer biomarkers in blood.

[LungLife AI @LungLifeAI]

Our LungLB test is a game-changer in lung cancer detection! 🌟 With rising lung cancer rates in never-smokers, we are committed to addressing this need. Early detection for everyone, everywhere. 💙

#LungLifeAI #LungLB #EarlyDetection #LungCancerAwareness #HealthInnovation

[LungLife AI @LungLifeAI]

Getting tested for lung cancer has never been easier! Join us in making early detection accessible and convenient. 🩸💙

#EarlyDetection #LungCancerAwareness #HealthInnovation

[LungLife AI @LungLifeAI]

LungLife AI is at the forefront of revolutionizing early lung cancer detection with cutting-edge technology. Early detection saves lives—spread the word and support innovative solutions! 💙

#LungLifeAI #EarlyDetection #LungCancerAwareness #HealthInnovation

[LungLife AI @LungLifeAI]

Our CEO Paul Pagano recently spoke with @Medtech_Insight, providing an overview of our LungLB test and the need for early lung cancer detection, as well as our journey towards reimbursement.

Listen to the episode here: https://t.co/51pEfL3POF

[LungLife AI @LungLifeAI]

Delighted to have our CEO, Paul Pagano present at the recent Early Detection Research Network conference; and even more delighted that our test is receiving recognition by such a prestigious body.

https://t.co/2rkzigrE9z

#LLAI

[Walbrook PR @WalbrookPR]

LungLife AI (AIM: #LLAI, @LungLifeAI) Notice of AGM

📅4:00 P.M. (BST) on 5 June 2024
📪Annual Report & Accounts posted to shareholders

🔗https://t.co/0Pz5nRkL84

[LungLife AI @LungLifeAI]

LungLife has been invited to present at @theNCI Early Detection Research Network (#EDRN) meeting in Tempe, Arizona today.

Read the full announcement including details of the presentation here: https://t.co/X8FYvMansn

[Walbrook PR @WalbrookPR]

Fantastic to see Walbrook clients @LungLifeAI (AIM: #LLAI) and @GenIncode (AIM: #GENI) covered in @SHARESmag's recent article 'Invest in the Future of Medicine', covering some of the most innovative companies working in AI, robotics and genetics.

https://t.co/u6yQ0UW82I

[LungLife AI @LungLifeAI]

Great to be highlighted in @SHARESmag's recent feature 'Invest in the Future of Medicine', covering some of the most innovative technology companies in medicine.

Read the piece below (behind paywall) https://t.co/IwGlhyUzth

#LLAI

[Vox Markets @VOXmarkets]

Q&A with Lunglife AI CEO, Paul Pagano
#AIM #LLAI @LungLifeAI #clinicaldiagnostics #lungcancer

Watch the Q&A here: https://t.co/LoRmuSfoK5

#investing #shares #voxmarkets via @VOXmarkets

[LungLife AI @LungLifeAI]

*WATCH* the latest investor presentation with LungLife CEO, Paul Pagano and CFO David Anderson following the Company's full year results for 2023.

https://t.co/SHedp2ze49

#LLAI

[LungLife AI @LungLifeAI]

LungLife AI announces its audited preliminary results for the year ended 31 December 2023.

Read the full announcement here:
https://t.co/O5NFOtfTaA

#LLAI

[Walbrook PR @WalbrookPR]

LungLife AI (AIM: #LLAI, @LungLifeAI) FY Results

Highlights

💷Cash of $2.83m
✅LungLB PLA code 0317U added
📚Multi-site validation of LungLB published
⭐️Successful clinical validation of LungLB test - PPV 81%
💰Fundraise of $2.28m

🔗https://t.co/IYUaohh05L

[Walbrook PR @WalbrookPR]

.@Investec has reiterated its Buy rating for @LungLifeAI following today's FY results.

⭐️ Recent validation data and expected Medicare coverage highlight commercial opportunity for LungLB®
🛣️ Early licensing/partnering strategy set up near-term catalysts
🎯 TP: 229p (CP: 30p)

[Vox Markets @VOXmarkets]

LungLife AI: Unlocking value in lung cancer diagnostics
#AIM #LLAI @LungLifeAI @CapitalPmh #AI #diagnostics

Read the article here: https://t.co/mfabxSUuCR

#investing #shares #voxmarkets via @VOXmarkets

[LungLife AI @LungLifeAI]

LungLife will announce its full year results on Thursday 4 April 2024.

Paul Pagano, CEO, and David Anderson, CFO, will be hosting a presentation via the @InvestorMeetCo platform at 4.00pm (BST) on Friday 5 April 2024.

https://t.co/e4phAfSYVd

[LungLife AI @LungLifeAI]

*WATCH* LungLife AI CEO, Paul Pagano as he discusses the successful validation of the Company's LungLB test with @proactive_UK

#LLAI

[Proactive @proactive_x]

$LLAI LungLife AI announces success in Validation of LungLB in multi-site, prospective clinical study https://t.co/R6CRc9OFTN @lunglifeai #LLAI

[LungLife AI @LungLifeAI]

We are pleased to announce the successful validation of the LungLB® test for indeterminate lung nodules from a prospective, multi-site clinical study in the clinically important small nodules patient group.

Read the full announcement here:
https://t.co/qKFkghleTN

#LLAI

[Proactive @proactive_x]

$LLAI LungLife AI shares jump 43% after validation of cancer diagnostic https://t.co/lVPM5KuQ3R @lunglifeai #LLAI

[Vox Markets @VOXmarkets]

LungLife AI shares soar after successful validation of lung cancer test

@LungLifeAI #LLAI #AIM #diagnostics

Read more here: https://t.co/gmlX39OpRO